AstraZeneca has become a Pharmaceutical Partner of the 5th Eurasian Pharmaceutical Summit

Global Pharmaceutical Leaders’ Club announces that AstraZeneca has joined the Eurasian Pharmaceutical Summit 2024 as a Pharmaceutical Partner. 

AstraZeneca stands at the forefront of the biopharmaceutical industry, driven by a commitment to science and innovation. With its headquarters in the UK, this global powerhouse is dedicated to discovering, developing, and commercializing prescription medicines in oncology, rare diseases, and various biopharmaceutical sectors, including cardiovascular, renal, metabolism, respiratory, and immunology. Operating in over 100 countries, AstraZeneca’s trailblazing treatments improve the lives of millions of patients around the world.

Detailed information about the company.

Leave a Reply

Your email address will not be published. Required fields are marked *